Furthermore, mTOR inhibitors have demonstrated efficacy in the treatment of psoriasis and other autoimmune diseases, highlighting the importance of this pathway in the pathogenesis of PsA (Kaplan et al., 2014; Raychaudhuri and Raychaudhuri, 2014). This evidence concerns the gene MTOR and psoriasis.